Kymera Therapeutics
KYMR
KYMR
119 hedge funds and large institutions have $1.39B invested in Kymera Therapeutics in 2022 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 48 increasing their positions, 37 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
5.76% more ownership
Funds ownership: 96.53% → 102.29% (+5.8%)
6% less funds holding
Funds holding: 126 → 119 (-7)
29% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 21
Holders
119
Holding in Top 10
4
Calls
$30.2M
Puts
$9.44M
Top Buyers
| 1 | +$42M | |
| 2 | +$29.5M | |
| 3 | +$19.9M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$13M |
| 5 |
AG
Artal Group
Luxembourg
|
+$12.5M |
Top Sellers
| 1 | -$22.2M | |
| 2 | -$10.5M | |
| 3 | -$5.7M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$5.06M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$2.93M |